2019
DOI: 10.1111/jop.12969
|View full text |Cite
|
Sign up to set email alerts
|

Tumor‐infiltrating lymphocyte‐derived MLL2 independently predicts disease‐free survival for patients with early‐stage oral squamous cell carcinoma

Abstract: Background MLL2 (mixed‐lineage leukemia 2) is recognized as an essential role in regulating histone 3 lysine 4 tri‐methylation (H3K4me3) in mammalian cells. It is frequently mutated to promote developmental diseases and tumor initiation. However, the expression pattern of MLL2 and its clinical significance for patients with early‐stage oral squamous cell carcinoma (OSCC) remain totally unknown. Methods Eighty‐five samples of primary early‐stage OSCC were enrolled in this retrospective study, and immunohistoche… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…Staining intensity was defined as 0, negative staining; 1, weak staining; 2, moderate staining and 3, strong staining. Final immunohistochemical scores were calculated by multiplying the percentage score and the intensity score 55 .…”
Section: Sequential Fluorochrome Labelingmentioning
confidence: 99%
“…Staining intensity was defined as 0, negative staining; 1, weak staining; 2, moderate staining and 3, strong staining. Final immunohistochemical scores were calculated by multiplying the percentage score and the intensity score 55 .…”
Section: Sequential Fluorochrome Labelingmentioning
confidence: 99%
“…The included studies were conducted in 16 different countries, that is Austria, 23 Brazil, 24 Canada, 25,26 China, 27,28 Denmark, 29,30 France, 31,32 Germany, 33 India, 34–36 Japan, 37 Malaysia, 38 Pakistan, 39 Poland, 40 Taiwan, 41,42 Thailand, 43 the Netherlands, 44 and the United States of America 45–55 . All of them were published in English between 2011 and 2022.…”
Section: Resultsmentioning
confidence: 99%
“…From 2005 to 2017, 96 primary OSCC patients were enrolled. The inclusion and exclusion criteria of patients were the same as those of our previous studies ( 18 ). These patients were followed up for 2–60 months, and the median was 39 months.…”
Section: Methodsmentioning
confidence: 99%